Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials

Overview of attention for article published in BMC Cancer, August 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 1 X users, with an upper bound of 906 followers.

New article: Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials https://t.co/syIhCXvEqu #gastriccancer #oncology https://t.co/HG7yaeEKVs

Reply Repost Favourite

New article: Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials https://t.co/FmPChoWPAc #breastcancer #oncology https://t.co/uhxI0WlHMA

Reply Repost Favourite

New article: Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials https://t.co/MHPwfdFiiF #pancreaticcancer #oncology https://t.co/anhN3GzrtJ

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.